Our study illustrated the characteristics of SAMD13 role in patients with HCC using various bioinformatics tools and highlights its potential role as a therapeutic target and promising biomarker for prognosis in HCC. The gene discussed is SAMD13; the disease is hepatocellular carcinoma.